Treatment

Everolimus Zentiva 2,5 mg Tabletten, PF-07850327 round, Everolimus Zentiva 5 mg Tabletten, ARV-471 clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingHuman Pharmacology (Phase I)- Other
A Phase 1b Trial of ARV-471 in Combination with Everolimus in Patients with ER+, HER2– Advanced or Metastatic Breast Cancer
This study is testing a new combination of two drugs, ARV-471 and Everolimus, for advanced breast cancer that has specific characteristics (ER+, HER2-). Doctors want to find the safest dose and see how well patients tolerate this new treatment. It's an early-stage study.
For: ER+, HER2– Advanced or Metastatic Breast Cancer
Spain